KUALA LUMPUR, Sept 7 -- Bintai Kinden Corp Bhd's subsidiary, Bintai Healthcare Sdn Bhd and NGT Solutions (M) Sdn Bhd (NGTS), an appointed healthcare organiser of Duopharma Biotech Bhd (Duopharma), will jointly distribute China’s Sinopharm COVID-19 vaccine to the Malaysian private sector.
In a statement today, Bintai Kinden executive director Azri Azerai said the collaboration between Bintai Healthcare and NGTS will enhance and expand its capability to offer a wider range of products and services, including the distribution of medical devices and healthcare solutions.
“We have the facility to store and distribute COVID-19 vaccines as Bintai Healthcare is the exclusive distributor for Greenie Medi Cold Chain Box in Malaysia.
“We aim to achieve a sales forecast vaccination for 5,000 persons in the first three months once the vaccine is made available to the private sector,” he said.
Under a business collaboration agreement sealed between the parties, NGTS will be providing the manpower and clinical resources including personal protective equipment and medical equipment to assess, vaccinate and monitor individuals, as well as managing emergencies during the vaccination process.
Duopharma was granted conditional approval by the Drug Control Authority of Malaysia on July 16, 2021, for Sinopharm’s COVILO COVID-19 vaccine.
The approval allows Duopharma to supply the vaccine to the private sector through local marketing and distribution rights that have been secured for the vaccine.
-- BERNAMA
BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 IFLIX channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
© 2024 BERNAMA • Disclaimer • Privacy Policy • Security Policy